Skip to Main Content

Paper Details

Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.
J Clin Oncol
27
2022
Author NameAffiliation
Fatima CardosoChampalimaud Clinical Center/Champalimaud Foundation
Coralie Poncet
Laura J Van't VeerUCSF Helen Diller Family Comprehensive Cancer Center
  • 1 - 3

Datasets

Release 1.2